Bicocca Open Archive

Logo unimib boa

Redaelli, S., Mologni, L., Rostagno, R., Piazza, R., Viltadi, M., Wise, S., et al. (2010). A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036. In American Society of Hematology, ASH Annual Meeting 2010 (pp.1391-1391). W.B. Saunders.

A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036

REDAELLI, SARA;MOLOGNI, LUCA;ROSTAGNO, ROBERTA;PIAZZA, ROCCO GIOVANNI;VILTADI, MICHELA;GAMBACORTI PASSERINI, CARLO
2010
abstract + poster
BCR/ABL1, L248R, Inhibitors, Resistance, Chronic Myeloid Leukemia
English
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
DEC 04-07, 2010
American Society of Hematology, ASH Annual Meeting 2010
BLOOD
2010
116
21
1391
1391
none
Redaelli, S., Mologni, L., Rostagno, R., Piazza, R., Viltadi, M., Wise, S., et al. (2010). A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036. In American Society of Hematology, ASH Annual Meeting 2010 (pp.1391-1391). W.B. Saunders.
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/37566
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact